MNKD Mannkind Corp

MannKind Corp is a development stage biotech firm. It is engaged in the discovery, development, and commercialization of therapeutic products for diseases such as diabetes and cancer.

$3.15  -0.08 (-2.48%)
As of 10/05/2022 15:59:58 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  07/28/2004
Outstanding shares:  252,565,400
Average volume:  5,733,410
Market cap:   $780,427,086
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BF081J4
Valuation   (See tab for details)
PE ratio:   -8.68
PB ratio:   -3.12
PS ratio:   11.15
Return on equity:   40.51%
Net income %:   -134.30%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy